Abvc Biopharma (ABVC) Change in Cash (2010 - 2026)
Abvc Biopharma's (ABVC) quarterly Change in Cash came in at -$1.2 million in Q1 2026, down 1038.32% YoY from $126467.0 in Q1 2025, and down 350.84% on a QoQ basis from $473074.0 in Q4 2025.
Abvc Biopharma (ABVC) Change in Cash (2010 - 2026) Analysis & Trends
Abvc Biopharma (ABVC) has 17 years of Change in Cash data on file, last reported at -$1.2 million in Q1 2026.
- Quarterly Change in Cash fell 1038.32% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$619244.0 (down 715.76% YoY) and the FY2025 annual result came in at $463170.0, up 215.01% from the prior year.
- Change in Cash eased to -$1.2 million in Q1 2026, from $473074.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $473074.0 in Q4 2025 to a low of -$3.1 million in Q1 2022.
- A 5-year average of -$377934.8 and a median of -$57778.0 in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2025 — Change in Cash soared 403.58% — and 2026, when it slumped 1038.32%.
- Tracing ABVC's Change in Cash over 5 years: stood at -$578419.0 in 2022, then jumped by 30.13% to -$404157.0 in 2023, then surged by 123.24% to $93942.0 in 2024, then soared by 403.58% to $473074.0 in 2025, then slumped by 350.84% to -$1.2 million in 2026.
- The last three Change in Cash figures came in at -$1.2 million (Q1 2026), $473074.0 (Q4 2025), and -$222415.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | -108,380.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -108,380.00 |
| Mar 31, 2026 | -1.19 Mn |
| Dec 31, 2025 | 473,074.00 |
| Sep 30, 2025 | -222,415.00 |
| Jun 30, 2025 | 316,758.00 |
| Mar 31, 2025 | -104,247.00 |
| Dec 31, 2024 | 93,942.00 |
| Sep 30, 2024 | 27,104.00 |
| Jun 30, 2024 | 83,767.00 |
| Mar 31, 2024 | -57,778.00 |
| Dec 31, 2023 | -404,157.00 |
| Sep 30, 2023 | 378,748.00 |
| Jun 30, 2023 | -1.05 Mn |
| Mar 31, 2023 | 400,150.00 |
| Dec 31, 2022 | -578,419.00 |
| Sep 30, 2022 | -1.63 Mn |
| Jun 30, 2022 | 166,658.00 |
| Mar 31, 2022 | -3.13 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | 2.79 Mn |